Ad
TSVT Quote Trading Chart 2seventy bio Inc.
home / stock / tsvt / tsvt quote
Quote | 2seventy bio Inc. (NASDAQ:TSVT)
| Last: | $3.78 |
|---|---|
| Change Percent: | 0.5% |
| Open: | $3.96 |
| Close: | $3.78 |
| High: | $3.97 |
| Low: | $3.77 |
| Volume: | 130,612 |
| Last Trade Date Time: | 12/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
TSVT Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $3.78 | $3.96 | $3.78 | $3.97 | $3.77 | 130,612 | 12-03-2024 |
| $3.98 | $4 | $3.98 | $4.14 | $3.96 | 169,159 | 12-02-2024 |
| $3.99 | $3.97 | $3.99 | $4.11 | $3.97 | 92,979 | 11-29-2024 |
| $3.96 | $3.72 | $3.96 | $4.03 | $3.69 | 208,245 | 11-28-2024 |
| $3.96 | $3.72 | $3.96 | $4.03 | $3.69 | 208,245 | 11-27-2024 |
| $3.69 | $3.72 | $3.69 | $3.79 | $3.61 | 154,504 | 11-26-2024 |
| $3.75 | $3.68 | $3.75 | $3.84 | $3.55 | 511,723 | 11-25-2024 |
| $3.61 | $3.16 | $3.61 | $3.7294 | $3.16 | 483,252 | 11-22-2024 |
| $3.16 | $3.11 | $3.16 | $3.17 | $3.02 | 230,617 | 11-21-2024 |
| $3.11 | $3.22 | $3.11 | $3.22 | $3.02 | 314,697 | 11-20-2024 |
| $3.22 | $3.41 | $3.22 | $3.41 | $3.2 | 351,117 | 11-19-2024 |
| $3.36 | $3.53 | $3.36 | $3.585 | $3.31 | 483,166 | 11-18-2024 |
| $3.52 | $3.96 | $3.52 | $3.96 | $3.51 | 414,780 | 11-15-2024 |
| $3.92 | $4.13 | $3.92 | $4.3195 | $3.9 | 283,607 | 11-14-2024 |
| $4.13 | $4.39 | $4.13 | $4.47 | $4.125 | 220,091 | 11-13-2024 |
| $4.28 | $4.58 | $4.28 | $4.77 | $4.23 | 344,696 | 11-12-2024 |
| $4.6 | $4.73 | $4.6 | $4.82 | $4.57 | 212,186 | 11-11-2024 |
| $4.73 | $5.02 | $4.73 | $5.04 | $4.685 | 211,505 | 11-08-2024 |
| $5.01 | $4.98 | $5.01 | $5.12 | $4.88 | 1,230,520 | 11-07-2024 |
| $4.95 | $4.94 | $4.95 | $5.04 | $4.74 | 797,028 | 11-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2seventy bio, Inc . (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the financial results conference call live via webcast which will be available on the ...
-
2seventy and Bristol Myers Squibb discontinue enrollment in Phase 3 KarMMa-9 study Decision results in over $80 million in anticipated cost savings for 2seventy over the next several years and accelerates path to breakeven in 2025 Expanded 3L+ label drives re-acceleration in Abe...
-
2seventy bio, Inc . (Nasdaq: TSVT), announced today that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 22 nd Annual Global Healthcare Conference on September 6, 2024 at 12:20 p.m. ET in New York. A live webcast of the fireside chat wil...